In China, the coronavirus COVID-19 pandemic could cause a prolonged effect in the pharmaceutical market. In 2020, the sales value of Chinese pharmaceutical market was forecasted increase by 6.1 percent compared with the previous year before the epidemic. The coronavirus crisis would likely slow down the growth to 2.4 percent.

Market Size statistics on the Pharmacies & Drug Stores industry in United States

The global Online Pharmacy market size is expected to reach USD 361.93 Billion in 2032 registering a CAGR of 16.4%. Discover the latest trends and analysis on the Online Pharmacy Market. Our report provides a comprehensive overview of the industry, including key players, market share, growth opportu...

Pharmacies and drug stores have endured moderate volatility in recent years. Retailers have benefited from a growing and aging population, as older consumers require medication to address chronic ailments, resulting in higher volumes of foot traffic. Similarly, the number of people with private insurance and public funding for Medicare and Medicaid has been on the rise, giving more people access to insurance and supporting demand for prescriptions, pharmacies' largest product segment. These trends, along with consumers increasingly prioritizing their health, have supported revenue gains, causing revenue to grow at an estimated CAGR of 1.1% to $609.6 billion through the end of 2025, including growth of 3.6% that year alone. Pharmacies have endured some challenges during this time, including heightened external competition from big-box stores and online-only pharmacies. With big-box stores offering consumers added convenience, pharmacies have expanded their services to offer some primary care services and grow delivery offerings. Many pharmacies and drug stores have invested in online platforms to service customers who prefer to shop online. The trend of online shopping will intensify in the coming years, and successful drugstores will be positioned to capitalize on the surge in demand. Pharmacies and drug stores have also focused on marketing personal care products, which often have higher prices, to capture additional revenue; however, unfavorable macroeconomic conditions directly harm these product lines because of their less-essential nature and higher access to substitutes. Pharmacies and drug stores will continue to benefit from the ongoing economic recovery, as cooling inflation encourages consumers to make more discretionary purchases like cosmetics and other personal care products. This growth will be fueled by the expansion of store services, including preventive care options and additional front-end offerings. As the number of insured individuals swells, many consumers will continue to fill their prescriptions because of the low out-of-pocket costs. As conditions for the industry improve, so will profit, rising along with revenue. Revenue is expected to climb at a CAGR of 2.6% to $692.0 billion through the end of 2030.

The global pharmacy market size is expected to grow from USD 2.4 trillion in 2024 to USD 2.5 trillion in 2025 and USD 4.1 trillion by 2035, at a CAGR of 5%

The size of the Pharmacy Market was valued at USD 543.15 billion in 2024 and is projected to reach USD 674.39 billion by 2033, with an expected CAGR of 3.14% during the forecast period. The pharmacy market is a multifaceted and dynamic industry involving the manufacturing, distribution, and dispensation of drugs and other health products. It involves the existence of multiple players, ranging from drug manufacturers and wholesalers to retail drugstores and internet pharmacies. The market plays a very significant role in making patients accessible to required medications and pharmaceutical therapy. There are a number of drivers to the pharmacy market, such as an aging population, growing rates of chronic conditions, higher health expenditure, and developments in research and development by pharmaceuticals. The market is also driven by regulatory environment, price controls, and the reimbursement model. The market is dominated by the retail pharmacy segment, with a vast network of physical pharmacies selling prescription and over-the-counter drugs, along with other health care services. Online pharmacies are gaining popularity, however, as they offer convenience and accessibility, especially in areas with poor access to health care facilities. Challenges faced by the industry are rising drug costs, mounting competition, and ensuring the safety and efficacy of drugs. Yet, the increased demand for healthcare services and ongoing innovation in pharmaceutical products are likely to propel the pharmacy market's growth in the next few years.

Online Pharmacy Market Outlook

The global online pharmacy market size was valued at approximately USD 68.8 billion in 2023 and is projected to reach around USD 203 billion by 2032, registering a compound annual growth rate (CAGR) of 13%. This remarkable growth is driven by the increasing adoption of digital technologies in healthcare and the convenience offered by e-commerce platforms. As consumers become more comfortable with purchasing goods and services online, the online pharmacy sector is witnessing a surge in demand. This trend is further bolstered by the growing prevalence of chronic diseases, which has led to increased demand for medications and healthcare products, coupled with the need for cost-effective and efficient delivery systems. Moreover, the COVID-19 pandemic has significantly accelerated the shift towards digital and remote healthcare solutions, further propelling the growth of online pharmacies worldwide.

One of the key growth factors in the online pharmacy market is the increasing penetration of the internet and smartphone usage globally. As more individuals gain access to online platforms, the ease of purchasing medications online becomes a significant draw. This increased connectivity allows consumers to compare prices, access a wider range of products, and read reviews, all of which contribute to a more informed purchasing decision. Additionally, the convenience of home delivery services offered by online pharmacies is a crucial factor driving market growth. For elderly and mobility-challenged individuals, in particular, this service eliminates the need for physical travel, making medication adherence more manageable. Furthermore, the integration of advanced technologies such as artificial intelligence and machine learning in online platforms enhances customer experience by providing personalized recommendations and efficient order processing.

Another substantial growth driver is the rising healthcare expenditure and the continuous efforts by governments to improve healthcare infrastructure. Online pharmacies present an opportunity for governments and healthcare systems to reduce costs associated with the distribution of medicines. By digitalizing the supply chain, online pharmacies can offer medications at lower prices than traditional brick-and-mortar stores, thereby increasing accessibility for lower-income populations. Additionally, partnerships between online pharmacies and pharmaceutical companies are becoming more common, which helps to streamline supply chains and improve the availability of medications. However, the online pharmacy market is not without its challenges, including regulatory hurdles and concerns about counterfeit medications. These issues necessitate robust regulatory frameworks and technological solutions to ensure product authenticity and consumer safety.

Moreover, consumer preference for online shopping is profoundly impacting the retail pharmacy landscape. With the increasing trend towards self-medication and the availability of over-the-counter drugs online, more individuals are opting to manage their health independently. This shift is supported by the availability of comprehensive information about medications and their uses on online platforms, empowering consumers to make informed decisions. Additionally, the growing awareness of health and wellness among consumers is driving demand for a wider range of healthcare products, including supplements and personal care items, further expanding the scope of online pharmacies. As these trends continue to evolve, the online pharmacy market is poised for sustained growth in the coming years.

The advent of the Pharmacy Delivery App has revolutionized the way consumers access medications, providing a seamless and efficient method for obtaining prescriptions and over-the-counter products. These apps have become an integral part of the online pharmacy ecosystem, offering features such as real-time order tracking, personalized notifications, and easy prescription management. By leveraging mobile technology, pharmacy delivery apps enhance the convenience factor, allowing users to order medications from the comfort of their homes and receive them at their doorstep. This is particularly beneficial for individuals with mobility challenges or those living in remote areas with limited access to physical pharmacies. As the demand for digital solutions in healthcare continues to rise, pharmacy delivery apps are poised to play a pivotal role in shaping the future of the online pharmacy market.

From a regional perspective, North America and

This statistic shows a forecast of the annual growth rate (CAGR) for the world's most important key markets in the pharmaceutical industry from 2008 to 2013.

The pharmaceutical eCommerce market value is estimated to be US$ 75,527.4 million in 2024. The market is predicted to grow at a CAGR of 14.4% during the forecast period. The market valuation is estimated to reach US$ 290,824.8 million by 2034.

Report Attribute	Details
Pharmaceutical eCommerce Market Size (2024)	US$ 75,527.4 million
Anticipated Market Value (2034)	US$ 290,824.8 million
Projected Growth Rate (2024 to 2034)	14.4% CAGR

Historical Analysis of the Pharmaceutical eCommerce Market Vs Demand Outlook

Attributes	Details
Pharmaceutical eCommerce Market Value (2019)	US$ 54,772.1 million
Historical Market Revenue (2023)	US$ 73,315.6 million
Historical CAGR (2019 to 2023)	7.6%

Country-wise Insights

Countries	CAGR (2024 to 2034)
United States	7%
Germany	8%
United Kingdom	8.7%
India	20.7%
China	16%

Category-wise Insights

Attributes	Details
Top Product Type	Over-the-counter Product
Market Share in 2024	63.7%

Attributes	Details
Top End User	Consumer or Individuals
Market Share in 2024	29.8%

Pharmaceutical eCommerce Market Report Scope

Attribute	Details
Estimated Market Size (2024)	US$ 75,527.4 million
Projected Market Size (2034)	US$ 290,824.8 million
Anticipated Growth Rate (2024 to 2034)	14.4%
Forecast Period	2024 to 2034
Historical Data Available for	2019 to 2023
Market Analysis	US$ million or billion for Value and Units for Volume
Key Regions Covered	North America, Latin America, Europe, Middle East & Africa (MEA), East Asia, South Asia and Oceania
Key Segments Covered	By Product Type, By End Use Verticals, and By Region
Key Companies Profiled	Netmeds Marketplace Ltd. EasyMedico Medlife Amazon. Inc Apotek The Kroger Co. Walgreen Co. Giant Eagle, Inc. Walmart Express Scripts CVS Health Optum, Inc. L Rowland & Co (Retail) Ltd Zur Rose Group AG McKesson Corporation SHOP-APOTHEKE EUROPE N.V. UK Meds Direct Ltd. Walgreens Boots Alliance, Inc. DocMorris
Report Coverage	Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing	Available upon Request

The global retail pharmacy market is a substantial and rapidly expanding sector, projected to reach a value of $1,776,690 million in 2025, exhibiting a robust Compound Annual Growth Rate (CAGR) of 5.2%. This growth is fueled by several key factors. The aging global population necessitates increased healthcare access and medication management, driving demand for retail pharmacy services. Furthermore, the increasing prevalence of chronic diseases, such as diabetes and hypertension, requires ongoing medication adherence, boosting the need for convenient prescription refills and related healthcare services offered by retail pharmacies. The rise of online retail pharmacies offers increased convenience and accessibility, particularly in underserved areas, significantly contributing to market expansion. Technological advancements, including telepharmacy and medication management apps, further enhance patient care and streamline operational efficiency for pharmacies. Competitive pressures among major players like Walgreens Boots Alliance, CVS Health, and MedPlus are stimulating innovation and investment in improving services and expanding reach. This competitive landscape, coupled with strategic mergers and acquisitions, further shapes market dynamics. However, the market faces certain challenges. Regulatory hurdles and varying healthcare reimbursement policies across different regions create operational complexities and impact profitability. The increasing cost of medications and the pressure to control healthcare expenditure place pressure on both pharmacies and consumers. Furthermore, maintaining data security and patient privacy in the face of growing digitalization is a critical concern. Despite these restraints, the long-term outlook for the retail pharmacy market remains positive, driven by persistent growth in healthcare expenditure, an aging population, and technological advancements that enhance efficiency and accessibility. The market segmentation, encompassing community, consult, home care pharmacies, and varied applications across schools, communities, hospitals, and online retail, presents multiple avenues for growth and specialization within the industry. This diverse landscape ensures significant opportunities for innovation and expansion in the coming years.

In 2024, the growth rate of Brazil's pharmaceutical market stood at ** percent, which was the highest growth rate among leading national pharmaceutical markets. Pharma companies in Brazil ACHE, which is a Brazilian-owned corporation founded in 1966, is among the leading pharmaceutical companies in Brazil, with a revenue of around six billion Brazilian reals (around *** billion U.S. dollars). Around half of the top ten companies were domestic and included enterprises, such as Eurofarma, Neo Quimica, Libbs, and Mantecorp Farmasa. Pharmaceutical R&D Global pharmaceutical research and development expenditures in 2024 came to a total of over *** billion U.S. dollars. By 2030, R&D spending is expected to exceed over *** billion U.S. dollars, with pharmaceutical companies Roche and Johnson & Johnson being among the top leading companies.

The global market for 503B compounding pharmacies is anticipated to grow at a compounded annual growth rate (CAGR) of XX% from 2025 to 2033, reaching a market size of million by the end of the forecast period. The market growth is driven by the increasing prevalence of chronic diseases and the rising demand for personalized medicines. Compounding pharmacies offer customized medications that meet the specific needs of individual patients, which is expected to fuel the market growth. The market is segmented by application into online and offline, and by type into acetaminophen, phenylephrine, midazolam, esmolol, vancomycin, epinephrine, advocaine, fentanyl/bupivacaine, morphine, and other. The offline segment is expected to dominate the market due to the convenience and personalized services offered by brick-and-mortar pharmacies. By type, the acetaminophen segment is anticipated to hold the largest market share due to its wide range of applications and low cost. Key players in the market include Central Admixture Pharmacy Services, Nephron Pharmaceuticals Corporation, QuVa Pharma, Olympia Pharmacy, ASP Cares, Fagron Compounding Pharmacies, Athenex, Inc., Avella Specialty Pharmacy, Atlas Pharmaceuticals, Empower Pharmacy, and others. The market is expected to witness strategic partnerships and collaborations among these players to expand their product offerings and geographic reach. This report provides a comprehensive analysis of the 503B compounding pharmacy industry, with a focus on its concentration, key trends, dominating regions/countries/segments, product insights, driving forces, challenges, and emerging trends.

The global Pharma E-commerce market is experiencing robust growth, projected to reach a market size of $34.40 billion in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 16.27%. This expansion is fueled by several key drivers. The increasing adoption of online platforms for healthcare services, driven by convenience and accessibility, is a major catalyst. Consumers are increasingly comfortable purchasing prescription and over-the-counter medications online, particularly younger demographics who are digitally native. Furthermore, the expansion of high-speed internet access globally is broadening the reach of e-pharmacies, particularly in developing economies. The market is segmented into Rx (prescription) and OTC (over-the-counter) segments, with both showing significant growth potential. Technological advancements, such as improved security protocols and telehealth integration, further enhance consumer trust and adoption. While challenges such as stringent regulations regarding online pharmaceutical sales and concerns about counterfeit medications exist, the market's overall trajectory remains strongly positive. Competition is fierce among established players like Walgreens Boots Alliance Inc. and McKesson Corp., as well as emerging e-pharmacies, leading to innovative business models and pricing strategies. The geographic distribution reflects a strong North American and European market currently, however, rapid growth is anticipated in Asia Pacific regions as internet penetration and healthcare infrastructure improve. The forecast period from 2025 to 2033 indicates continued expansion, driven by ongoing digital transformation within the healthcare sector and evolving consumer preferences. Growth will likely be uneven across regions, with faster growth in developing economies compared to mature markets. However, even in established markets, e-pharmacies are actively seeking new revenue streams through personalized medicine recommendations, subscription services, and value-added services such as medication reminders and virtual consultations. Successful players will be those who effectively navigate regulatory hurdles, invest in robust security and logistics infrastructure, and build trust among consumers through transparent practices and personalized services. The continued integration of telemedicine and AI-powered diagnostic tools into e-pharmacy platforms will significantly shape future growth, further boosting market value.

Mail Order Pharmacy Market Outlook

The global mail order pharmacy market size was estimated at USD 85 billion in 2023 and is projected to reach approximately USD 145 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.5% during the forecast period. This significant growth can be attributed to several factors, including the increasing population of elderly individuals requiring chronic disease management, advancements in e-commerce and digital technologies, as well as heightened consumer preference for contactless purchase options. The ease of obtaining medications without the need for a physical visit to a pharmacy has driven not only consumer satisfaction but also operational efficiencies, thus contributing to the robust expansion of this market segment.

A major growth factor in the mail order pharmacy market is the rising prevalence of chronic diseases which necessitate long-term medication management. Conditions such as diabetes, hypertension, and arthritis, among others, have seen a rapid increase globally, subsequently elevating the demand for reliable and consistent access to medications. Mail order pharmacies offer a compelling solution by providing patients with the convenience of home delivery, potentially enhancing medication adherence. This service not only caters to the needs of patients with mobility issues but also those residing in remote or underserved areas where access to traditional pharmacies may be limited.

The growing adoption of digital health technologies is another significant factor driving the growth of the mail order pharmacy market. With the expansion of telemedicine services and e-health platforms, patients can now consult healthcare professionals and receive prescriptions virtually, further streamlining the process of obtaining medication through mail order pharmacies. The integration of artificial intelligence and machine learning tools has further optimized inventory management and personalized patient experiences, making the mail order pharmacy model more efficient and attractive to both consumers and providers. Such technological advancements have not only facilitated a better supply chain management but have also improved the accuracy of prescription fillings, thereby reducing errors and enhancing patient safety.

Economic factors also play a pivotal role in the expansion of mail order pharmacy services. With healthcare costs on the rise, both insurance providers and patients are seeking cost-effective solutions for medication procurement. Mail order pharmacies often provide more competitive pricing and bulk purchasing options, reducing overall costs for patients. Additionally, partnerships with insurance companies and healthcare providers have enabled mail order pharmacies to offer specialized services, such as medication synchronization and reminders, which help in reducing the rate of medication non-adherence, further driving market growth.

Regionally, North America continues to lead the mail order pharmacy market, driven by a well-established healthcare infrastructure and a high prevalence of chronic diseases. However, the Asia Pacific region is expected to witness the fastest growth during the forecast period, bolstered by increasing internet penetration, growing awareness of digital health solutions, and a burgeoning middle class with increasing healthcare demands. In Europe, government initiatives aimed at promoting digital health solutions are also contributing to market expansion. Each of these regions exhibits unique growth drivers and challenges, shaping the future trajectory of the mail order pharmacy industry.

Product Type Analysis

The mail order pharmacy market is segmented by product type into prescription drugs and over-the-counter (OTC) drugs. Prescription drugs constitute the larger share of this market segment due to the necessity of ongoing medication for chronic diseases such as cardiovascular disorders, diabetes, and mental health conditions. The convenience of receiving prescription drugs through mail order pharmacies has significantly improved adherence rates among patients with long-term medication needs. The availability of a wide range of prescription drugs supported by comprehensive insurance coverage has further fueled this segment's growth, making it a pivotal component of the mail order pharmacy landscape.

Over-the-counter drugs, while smaller in comparison to prescription medications, have seen increasing acceptance in the mail order pharmacy segment. This growth is attributed to consumer demand for convenience and the broad availability of OTC drugs for common ailments such

The compounding pharmacy industry finds itself increasingly at the center of legal actions initiated by pharmaceutical manufacturers. These lawsuits primarily focus on intellectual property violations, where manufacturers accuse compounding pharmacies of stepping beyond their regulatory boundaries by reproducing commercially available drugs. This uptick in litigation corresponds with the rise in compounding practices over the last five years despite the stricter regulatory framework under Section 503A of the Federal Food, Drug and Cosmetic Act, which stipulates the conditions under which compounded drugs do not require FDA approval. Despite the ongoing legal challenges, compounding pharmacies have embraced e-commerce to extend their reach beyond conventional geographic limitations. This shift has been catalyzed by the broader trend towards online healthcare solutions, accelerated by the pandemic and growing consumer demand for online services. Moreover, the aging US population, which often requires more personalized medication solutions for complex health conditions, has further fueled demand for compounded drugs. Overall, industry revenue is estimated to grow at a CAGR of 4.3% to reach $19.0 billion by 2024, including an expected 3.6% increase in 2024 alone. The continued demographic shift toward the older population is expected to necessitate more customized medications to meet the unique needs of older adults, which standard off-the-shelf drugs may not fulfill. Furthermore, the growth of e-commerce is poised to significantly influence the pharmaceutical industry. Online shopping offers convenience, which enhances patient satisfaction and drives the preference for pharmacies that provide easy online ordering and home delivery services. Technological advancements in pharmaceutical compounding will enhance the precision, efficiency and safety of the compounding process. Overall, industry revenue is projected to grow at a CAGR of 3.0% to reach $22.0 billion by 2029.

The Compounding Pharmacy Market Report is Segmented by Therapeutic Area (Pain Management, Hormone Replacement Therapy, and More), Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations), Age Cohort (Pediatric, Adult, Geriatric), Sterility (Non-Sterile, Sterile), and Geography (North America, Europe, Asia-Pacific, and More). The Market Forecasts are Provided in Terms of Value (USD).

The global online pharmacy market was valued at USD 109.74 billion in 2023 and is expected to reach USD 286.26 billion by 2029, growing at a CAGR of 17.33%.

The pharmaceutical retail market, encompassing prescription drugs, over-the-counter medications, health products, and medical apparatus, is a dynamic sector experiencing significant growth. Driven by factors such as an aging global population with increasing healthcare needs, rising prevalence of chronic diseases, and the expanding accessibility of online pharmacies, the market is projected to maintain a robust Compound Annual Growth Rate (CAGR). While precise figures are unavailable, considering typical growth rates in this sector, a conservative estimate of a 5% to 7% CAGR from 2025 to 2033 is reasonable. This growth is further fueled by the continuous innovation in pharmaceutical products and the increasing demand for convenient and accessible healthcare solutions. Major players like CVS Health and Walgreens Boots Alliance are consolidating their market share through strategic acquisitions and expansions, emphasizing the competitive landscape. However, the market also faces constraints such as stringent regulatory frameworks, pricing pressures, and the increasing prevalence of generic drugs. Segment analysis reveals that prescription drugs currently dominate the market, though the over-the-counter and health products segments are exhibiting strong growth potential, particularly driven by consumer interest in preventative healthcare and self-care. The retail channels are diversified, with independent retailers and pharmacy chains vying for market dominance. Geographically, North America and Europe currently hold the largest market share, but significant growth opportunities exist in emerging markets like Asia-Pacific and parts of Africa and South America, driven by rising disposable incomes and improving healthcare infrastructure. The ongoing trend of digitalization is profoundly impacting the market, with the increasing adoption of telehealth and online pharmacies creating new avenues for growth and potentially reshaping the traditional brick-and-mortar retail landscape.

The global pharmaceutical e-commerce market is experiencing robust growth, driven by increasing internet penetration, the convenience of online ordering, and a rising preference for telehealth services. This market, estimated at $150 billion in 2025, is projected to grow at a compound annual growth rate (CAGR) of 15% from 2025 to 2033. This significant expansion is fueled by several key factors. Firstly, the COVID-19 pandemic accelerated the adoption of online pharmacies, highlighting the convenience and safety of accessing medications remotely. Secondly, the growing elderly population, coupled with a rise in chronic diseases, necessitates convenient access to prescription refills and over-the-counter medications. Thirdly, the entry of major players like Amazon and established pharmacy chains into the online space is fostering competition and innovation, leading to improved services and lower prices. Furthermore, advancements in technology, such as mobile applications and telehealth platforms, are streamlining the online prescription process and enhancing patient engagement. However, challenges remain. Regulatory hurdles in certain regions, concerns about data privacy and security, and the need for robust verification systems to prevent counterfeiting and fraud are significant restraints. The market is segmented by prescription medications, over-the-counter products, and by gender (male and female), reflecting diverse consumer needs and preferences. Geographical distribution reveals strong growth in North America and Europe, driven by established healthcare infrastructure and high internet penetration rates. Emerging markets in Asia-Pacific are also showing significant potential, fueled by rapid economic growth and increasing healthcare spending. Competitive landscape analysis indicates a mix of established pharmaceutical companies, online marketplaces, and specialized e-pharmacies vying for market share. The projected CAGR of 15% suggests that the pharmaceutical e-commerce sector is poised for considerable expansion in the coming years, presenting both significant opportunities and challenges for stakeholders.

Canadian pharmacies and drug stores have been experiencing moderate volatility. Drug stores have benefitted from growing health-related expenditures, with prescription medications remaining popular among consumers. Although increasing pharmaceutical prices have bolstered revenue, many provincial drug programs restricted prescription prices to cut healthcare costs, requiring generic drugs to be marked down by a percentage of the patented drug equivalent, which limits revenue growth and prevents larger profit gains. Pharmacies have endured some losses as high inflation discourages discretionary spending, particularly in the beauty and personal care segment. Still, the essential nature of the industry and the consistent need for health products have supported revenue gains. These trends are set to cause revenue to grow at an estimated CAGR of 0.5% to $88.6 billion through the end of 2025, including a 1.9% gain that year alone. As more and more Canadians continue to rely on prescription drugs, foot traffic at pharmacies and drug stores will remain high. British Columbia's reference-based pricing model, which includes generic substitution reimbursement rates within particular product categories, has constrained pharmacies' ability to markup prescription prices for individuals with public health insurance. Pharmacies have also contended with the loss of many brand-name drug patents, markets flooded with low-cost alternatives and significant supply chain disruptions impacting product availability, slowing revenue gains. Despite more prescriptions entering the generic space, new brand-name drugs have been pushing prescription spending upward. Many pharmacies have also begun to offer primary care services, allowing the industry to support Canada’s health system and drive more traffic to stores. These programs, which vary across provinces and have yet to be implemented nationally, create growth opportunities for drug stores. Revenue growth will continue amid growing healthcare spending and an expanding Canadian population. As research and development expenditures continue to rise, more pharmaceuticals will likely come through manufacturers’ drug pipelines, benefitting pharmacies and drug stores. Similarly, improving macroeconomic conditions, including weaker inflation and rising disposable income, and improving supply chain conditions will support growth moving forward. Similarly, pharmacies offering more preventative care are set to contribute to revenue gains. Medications are nondiscretionary, so consumers will continue to buy these products despite price fluctuations. Revenue will grow at an estimated CAGR of 1.9% to $97.4 billion through the end of 2030.